Michael E. O'Dwyer

STI571, a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia: validating the promise of molecularly targeted therapy

Brian J. Druker, B. Druker, M. Mauro, 2001, Cancer Chemotherapy and Pharmacology.

The cancer glycome: carbohydrates as mediators of metastasis.

Lokesh Joshi, Irene M. Ghobrial, Michaela R. Reagan, 2015, Blood reviews.